SlideShare ist ein Scribd-Unternehmen logo
1 von 6
Downloaden Sie, um offline zu lesen
Informedia proudly presents the inaugural
conference on
For more details, visit www.globalpharma-summit.com
Best Practice in Service Outsourcing
Conference: 3rd - 4th December 2008 | Venue: Hotel J W Marriott, Mumbai
Global Pharmaceuticals
Research & Manufacturing India 2008
Global Pharmaceuticals
Research & Manufacturing India 2008
n
nActis Biologics
nAll India Institute of
Medical Sciences
nAmgen India
nAstraZeneca Pharma
nCadila Pharmaceuticals
nDr Reddy's Laboratories
nEisai India
nEli Lilly &Co.
nEvolva Biotech
nFDA Maharashtra State
nGlaxoSmithKline
Pharmaceuticals
nInstitute of Clinical
Research India
nNishith Desai Associates
nNovartis
nNycomed Pharma USA
nPfizer
nSandoz
nSanofi–Aventis
nTakeda Global Research
and Development
nUSV
nWockhardt
nWyeth
nZydus Cadila
Abbott India
Top Level Speakers from
Ü
Ü
Ü
Ü
Ü
Find out how to outsource your clinical trials to India
Harness the benefits of Indian CRAMS/CSOs within the
current global pharma business model
Evaluate the implications of moving global R&D offshore
to India
Examine the influence and input of biotech companies in
the Indian pharma market
Learn about the emerging and innovative business
models for partnerships and collaboration
Key Note Speakers
Mr Ranga Iyer
President OPPI and
Managing Director
Wyeth
Mr Suhas Chaudhari
Joint Commissioner
(Greater Mumbai)
FDA Maharashtra State
Uma Nandan Misra
Vice President -
Operations & Site Manager
AstraZeneca Pharma
Mr Ranjit Shahani
Vice Chairman,
Managing Director
and Country President
Novartis
Mr Harjit Singh,
Senior Development
Manager,
Takeda Global Research
and Development, UK
Principal
Media Partner
Media Partners
Online Media Partners
International
Media Partner
10.00 am Evaluating the implications of moving global R&D
offshore vs outsourcing to India
Globalisation of drug development processes
What impact will Indian CROs have on shaping the
global R&D landscape?
Indian CROs view on the offshoring operations -
how do they view their interaction and experiences
when working with US and European pharmas?
l
m
m
Dr Chandrashekhar Potkar
Managing Director, Clinical Research
Pfizer
8.30 am Registration
9.00 am Chairman's Welcome and Opening Address
9.35 am Harnessing the benefits of Indian CRAMS/CSOs
within the current global pharma business model
Comparing CRO (Contract Research Organisation) and
CM (Contract Manufacturing) activities within India,
externally and looking at prospects for future
development
Retrospective analysis of how the CRAMS/CSOs
business model has evolved - where we are now?
Analysis of the long-term prospects for the
CRAMS/CSOs industry and its ultimate effect on
the Indian pharma business
l
m
m
Dr Ish Khanna
Dr Reddy's Laboratories USA
Mr Ranjit Shahani
Vice Chairman, Managing Director and
Country President
Novartis
9.10 am Overview of the Indian pharma sector in an
economic context
What is the current development status of the
industry?
Is the cost advantage of investing in India now
diminishing because of escalating operating costs?
Dealing with the declining ROI of pharma
businesses - proposed solutions to maintain
sustainable growth of the industry
Indian pharma in comparison to other emerging
markets: China, South East Asia and Latin America
Evaluating offshore process outsourcing from a
regulatory and cost perspective
Predicting future prospects: how the Indian economy
is expected to develop - where will we be in 2020?
l
m
m
m
m
l
Globalisation of the Indian pharma industrySession I:
Wednesday 3rd December, 2008DAY 1:
2.40 pm Three years on from the Indian Patents Act 2005
Myths about patents
Features of the Act
Unfinished agenda
Path forward
l
l
l
l
Mr Ranga Iyer
President, OPPI and Managing Director
Wyeth
3.05 pm Pharmacovigilance, PMS and PSUR in India:
Current status and the road map. Assessing the
development of methodologies for monitoring
drug safety
Addressing the increasing concerns over drug safety
and post-approval surveillance
Ensuring proactive pharmacovigilance throughout
the product lifecycle
Improving patient safety by increasing the
transparency of safety data
Transferring the pharmacovigilance advancements of
the West to emerging markets
Exploring the relationship between
pharmacovigilance and risk management
l
l
l
l
l
Mr YK Gupta
Head, Department of Pharmacology,
Zonal Pharmacovigilance Centre
All India Institute of Medical Sciences
10.25 am Morning Refreshments & Networking Break
11.20 am The evolving regulation landscape in India
Discussing the current Indian regulatory environment
Recognising the requirements of Indian regulations
towards approval of drugs developed
Ensuring effective protection of intellectual property
rights and development processes
Standard operating procedures for conducting clinical
trials in India - Schedule Y of the Drugs and Cosmetics
Act in India and guidelines for biomedical research
l
l
l
l
Dr Surinder Singh
Drugs Controller General of India
*
Mr Suhas Chaudhari
Joint Commissioner (Greater Mumbai)
FDA, Maharashtra State
10.55 am Harmonisation of the global pharma regulatory
environment
Evaluating the impact of globalisation on the pharma
regulatory landscape and how this will affect research
and manufacturing processes
Finding a common set of regulations which are
acceptable to all countries
l
l
Indian and worldwide regulatory policies
and legislative framework
Session II:
2.00 pm The viewpoint from two industry specialists on
managing legal and regulatory considerations in
clinical outsourcing
The patent regime and present status of R&D in
India
Government initiatives to shorten the clinical
trials application time
Clinical research landscape in India
Discussing the market prospects for further
development
Analysing the reason for the gap in the amount of
research between India and the rest of the world
Investigating pharmacovigilance practices in India
for the clinical trials market and for future REITs
l
m
l
m
m
l
Dr SK Gupta, Director General
Institute of Clinical Research India
Ms Gowree Gokhale, Partner
Nishith Desai Associates
www.globalpharma-summit.com
For an Updated Conference Programme,
Please log on to:
* Awaiting final confirmation
12.30 pm Luncheon
11.45 am SPEED NETWORKING
The quicker way to do business
3rd - 4th December, 2008
Global PharmaceuticalsGlobal Pharmaceuticals
Research & Manufacturing India 2008
3.30 pm
Dr Sham Nikam, Chief Scientific Officer
Nycomed Pharma USA
Evaluating the current status of drug R&D in India
Drug discovery in India, along with CROs in Indian
pharma industry
Exploring the contract research market from
preclinical to phase 3
Emerging opportunities for conducting exploratory
proof-of concept studies
Trends on outsourcing drug discovery and
development (DD&D)
Producing cost-effective NCEs (New Chemical
Entities) targeting lifestyle, resistant infectious
diseases with improved efficacy and minimal side
effect
Producing a pipeline of promising drug candidates
- DD&D and NCEs
l
m
m
l
m
m
4.15 pm
Dr PM Murali, Managing Director
Evolva Biotech
Building an indigenous value based ecosystem for
cost effective drug discovery in India. Six key
aspects leading to a sub half billion dollar NDA in
the future Indian discovery landscape
INVESTMENT: Arrival of startup VCs redefining the
discovery landscape in India – those with longer
acceptable incubation periods for their ROI and a
higher risk taking ability
EXPERTISE: Influx of returning Indians from
elsewhere with prior experience in drug discovery and
development
FACILITIES: Availability of world class CRAMS/CSOs in
biology, chemistry and pharmacology
RESEARCH CONSULTANTS: Networking with scientific
clusters of excellence, who are willing to collaborate
with industry
INTERFACE & SCALEUP OPERATIONS: English
speaking population and FDA approved facilities –
both available with largest numbers outside United
States
CLINICAL TRIALS: Huge patient population with
diversity and CSIR's efforts in systematic mapping
of heterogenicity, enables effective clinical trials,
pharmacogenomics and pharmacovigilance
l
l
l
l
l
l
Dr Veena Jaguste, Director, Global Development
Operations, Amgen India
4.40 pm The impact of outsourcing on drug development
performance and implications for more effective
collaboration with CROs
Clinical research and trials outsourcing - overcoming
challenges and impediments
Incorporating emerging regions into clinical
development plans - a unique set of opportunities and
challenges
l
l
Mr Harjit Singh, Senior Development Manager
Takeda Global Research and Development UK
5.05 pm Clinical research and trials outsourcing -
challenges and hurdles in India
Conducting phase 1 and 2 clinical trials in India
Clinical quality assurance and its significance in global
drug registration
Clinical safety and risk evaluation in trials
Conducting ethical clinical trials
Managing clinical trial sites successfully
Feasibility studies for investigational site selection
Non clinical: technical and operational procedures and
how to address them
l
l
l
l
l
l
l
3.55 pm Afternoon Refreshments & Networking Break
Mr Sanjeev Saxena
Chairman and CEO
Actis Biologics
Evaluating the influence and input of biotech firms
on the Indian pharma market
Evaluating global biotechnology development and
India's role in the process
Ensuring global biotech opportunities within India and
overseas
Gaining advantage of innovative bio-technologies
Forming partnerships with Indian biotech firms
l
l
l
l
9.10 am
Thursday 4th December, 2008DAY 2:R&D in India: the landscape of opportunities
and challenges
Session III:
8.30 am Registration
9.00 am Chairman's Opening Remarks
Emerging trends in biotechnologySession IV:
Benefits of contract manufacturing
for Indian producers
Session V:
10.40 am Morning Refreshments & Networking Break
9.35 am
Mr Subash Kapre *
Executive Director
Serum Institute of India
Key issues affecting biopharmaceutical
manufacturing
Manufacturing biologics from the CMO (Contract
Manufacturing Organisation) perspective
Where is biopharma manufacturing going in the next
10 years?
Regulatory initiatives impacting biopharmaceutical
development and manufacturing
Entry of biosimilar and bio-generic products
Ensuring quality and safety in bio-processes
Strategies for ensuring product comparability and
safety after manufacturing process changes
l
l
l
l
l
m
10.00 am Global harmonisation and the perception of Indian
CM to the rest of the pharma industry
Evaluating international trends and global
harmonisation opportunities
CMO management throughout the relationship
between CMO and outsourcer lifecycle
Obtaining and understanding how process changes can
affect the structure and biological activity of the final
product (in technology transfer)
Implementing successful approaches in manufacturing
Evaluating the role of globalisation on the regulatory
landscape and manufacturing process
Contract manufacturing - in house vs outsourcing
Emerging fields in the pharma outsourcing market -
why should you outsource manufacturing and risk
costly technology transfer delays?
A critical assessment of the current manufacturing
outsourcing strategies
l
l
l
l
l
l
l
l
Mr Sanjit Lamba, President and CEO
Eisai India
Mr Lakshminarayana Neti, Director Operations
Abbott India
For enquiries write to
jayesh.kanaskar@informedia-india.com5.40 pm Informedia’s Cocktail Reception
5.30 pm Chairman's Closing Remarks and End of Day One
* Awaiting final confirmation
3rd - 4th December, 2008
Global PharmaceuticalsGlobal Pharmaceuticals
Research & Manufacturing India 2008
Mr Uma Nandan Misra
Vice President, Operations and Site Manager
AstraZeneca Pharma
11.50 am Case Study - Achieving operational excellence in
a pharma manufacturing plant
Cultural transformation
Aligning manufacturing priorities with business
Identifying & monitoring critical performance
parameters
Engaging all employees for continuous improvement
Achieving excellence in focussed areas
l
l
l
l
l
12.55 pm Luncheon
2.10 pm Implementing strategies to ensure that the
contractors comply with quality agreements
Compliance with GMP requirements
Demonstrating how cGMP is essential for survival in
the pharma business
Gain a competitive edge with a GMP compliant
designed facility
Learn the importance of well written procedures,
validation, documentation and SOPs for cGMP
compliance
l
m
m
m
Dr PM Naik
Project Director
Zydus Cadila
Evolving partnering and business modelsSession VI:
2.35 pm Implementation of risk management strategies in
outsourced manufacturing
Risk and risk management in pharmaceutical and
biopharmaceutical outsourcing
Measuring risk as a preventative technique -
ensuring operational excellence
Identifying, understanding and rating risk
throughout all processes
Implementing effective methods to avoid risk
Identifying and overcoming cost issues in CM
outsourcing
l
l
m
m
m
Mr TS Anand
Director, Contract Manufacturing and Outsourcing
Dr Reddy's Laboratories
3.00 pm Innovative models of collaborating opportunities
with CRAMS/CSOs
Different models of collaboration that can be
established between Indian firms and MNCs
New business and partnership models evolving in
India
In and out licensing of drug discovery research
Partnering opportunities - strategic involvements
l
l
l
l
Ms Mukta Arora
Head of Global Sourcing
Eli Lilly & Co.
3.45 pm External sourcing in the pharma space
Requirements for external sourcing
Basic aspects of external sourcing
Challenges faced by the Indian pharma business as
compared to international businesses and other
sectors
How do you choose the right partner?
Relationship building for the longer term - an essential
part of the pharma business
Legal and contractual issues
l
l
l
l
l
l
Mr Debabrata Gupta
Director and Chief Operating Officer
USV
4.45 pm
4.35 pm
End of Day Two and Close of the Conference
Chairman's Closing Remarks
4.10 pm What are the strengths that the outsourcing
organisation is looking for while selecting the
CRAMS/CSOs?
What the contract givers and contract acceptors
should be aware of to continue long-term business
relationships
Who is the owner of the intellectual property
developed during the cooperation and why?
How to face audits from the outsourcing organisation
to get approved as a CSO
Why continuous communication is essential in such a
relationship
Why the customer should be kept informed of the
failures and mistakes that take place
At what stage does the product need to be optimised
during CRO or CSO?
How process changes from established practice could
affect the customer and the relationship
l
l
l
l
l
l
l
Dr Sunil Kanvinde
Deputy General Manager, Technical Services
Sandoz
11.10 am Two key opinion leaders demonstrate how to
establish successful technology transfer in CMO
to ensure an effective manufacturing process
Technology transfer for outsourcing and contract
manufacture
Implementing technology transfer to ensure an
effective manufacturing process
Critical factors and timelines for a successful
technology transfer
Success factors during process comparability and
validation
Developing and implementing clear quality
agreements with CMOs
Incorporating knowledge to ensure process
comparability, validation and GMP requirements
l
l
l
l
l
l
Mr KK Ambardar, General Manager,
Contract Manufacturing, Cadila Pharmaceuticals
Dr Ashoke Banerjee, Executive Director
GlaxoSmithKline Pharmaceuticals
12.15 pm Panel Session:
Two industry leaders viewpoint on quality
management - developing and implementing
sustainable quality agreements with CMOs
What are the ‘rules of engagement’ between the
sponsor and client for proper management of mutual
quality and quality-regulatory needs in an outsourcing
arrangement?
One size does not fit all - How to design and put a
workable and sustainable quality management system
into practice?
How does a quality agreement separate or link to other
agreements like commercial and technical?
What are the regulatory and legal requirements that
should be addressed in a quality agreement?
How should critical quality activities of change
management, deviations, investigations, product
release, GMP audits and regulatory inspections be
integrated in to a good quality agreement?
l
l
l
l
l
Mr Satish Rajkondawar, Senior Director,
External Manufacturing Site, Sanofi-Aventis
Mr Viswajit Sahu, DGM Contract Manufacturing
Services, Wockhardt
3.25 pm Afternoon Refreshments & Networking Break
3rd - 4th December, 2008
Global PharmaceuticalsGlobal Pharmaceuticals
Research & Manufacturing India 2008
About Informedia
Informedia India Pvt Ltd is a leading conference organiser
which specialises in professional high level business
conferences targeted at senior management in a number of
industry sectors. We are a subsidiary company of the
Expomedia Group Plc., a leading International media group
with offices in 13 countries worldwide.
Dedicated to in-depth research, our conferences provide you
with relevant information about what you want to know, when,
and from whom. Straightforward and industry oriented, our
conferences are a very time efficient way to gain a head start
and secure your competitive advantage. Our focused events
create a platform to network with both new and experienced
peers from various industries and feature the most relevant
case scenarios in order to equip you with valuable knowledge
and current know-how.
www.informedia-india.com
Attracting the industry's most powerful and influential delegates
àBusiness Development
àClinical Research Outsourcing
àManufacturing
àDrug Discovery & Development
àMedical Affairs
àPharmaceutical Development
àPharmacoviligance
àPreclinical Development
àProcurement
àProduction Planning & Manufacturing
àPurchasing
àQuality Control & Assurance
àRegulatory Affairs
àRisk & Safety Assessment
Heads of Divisions
àCXOs
àProject Directors
Who will be there?
The Global Pharmaceuticals conference has been
developed with the following executives in mind:
Which industry sectors should attend?
àPharmaceutical Companies
àBiotech Companies
àCROs and CMOs
àPharmaceutical Manufacturers
àResearch Laboratories and Institutes
àBusiness Consulting Firms
àGovernment Institutions and Regulators
àPrivate Equity Funds
àVenture Capitalists
Sponsorship...
helps you to do business and deliver your message to the Global Pharmaceutical market.
Contact our Sponsorship Director on sponsorship@expomediagroup.com or
call +91 22-28500104 in India and +44 (0) 1923 491 067 in the UK to tailor your package
Q.1 Could you benefit from presenting a case study or hosting a
workshop in front of your target audience and demonstrating
your expertise?
If your answer is yes to any of these questions then the
Global Pharmaceuticals Research and Manufacturing India 2008 is
the most important place for you to be.
6 simple questions to determine value from sponsorship
Q.2 Do you want to do business with senior decision makers from
the leading Pharmaceutical and Biotech companies from
India, Asia and the rest of the World?
Q.3 Can you benefit from the impact of outsourcing on Clinical
Research or Contract Manufacturing?
Q.4 Can you provide a solution to the bad perception of
manufacturing from a CMO's perspective?
Q.6 Do you want to collaborate on drug development
performance with CRO's?
Q.5 Are you able to demonstrate the best way to run effective
proof of concept trials?
Sponsoring the Global Pharmaceuticals Research and
Manufacturing India 2008 forum will enable you to:
Raise your company’s profile
Increase your chances of being chosen as the logical choice of
supplier, when they hear and see you can exceed their needs.
Don't pass business opportunities by, whilst your competitors
walk away with them.
Find your all year round marketing solution
There are a limited number of opportunities for you to get
your message across to the leading International
Pharmaceutical and Biotechnology Companies, so act now to
avoid disappointment.
Put simply, you can't afford to miss out!
The conference helps you to overcome common business
development hurdles, like access and face to face networking
with the right people with hours of scheduled networking
time. Global Pharmaceuticals will put you face to face with
people that matter in this industry.
Join our existing partners at this prestigious event
REGISTRATION FORM HOTEL INFORMATION
Hotel J W Marriott
www.globalpharma-summit.com
I / We / would like to attend / nominate the following
Please tick
I enclose my Cheque/Draft payable to
INFORMEDIA INDIA PVT. LTD. by post at
204-205, Town Centre, Andheri-Kurla Road,
Sakinaka, Andheri (E), Mumbai - 400059
I am paying by bank transfer (copy attached)
I cannot attend this event but
I would like to purchase the Conference
Documentation for Euro 150 + 12.36 %
Service Tax
Please do not include me on your mailing list
REGISTER NOW in 3 Easy Steps
Call: Sarfraz Patel
Cell: +91 98 33487628
Tel: +91 22 40820183
Fax: +91 22 28509590
Register Online
www.globalpharma-summit.com
1
2
3
Delegate 1 Delegate 2 Delegate 3
Designation
Tel/Mobile/Fax
Email ID
Organisation
Address
Approving Authority
Name
Pin Code
Name/
Designation
Signature
Feesareinclusiveofallprogrammedocuments,lunchonbothconferencedaysandrefreshments.Thefeesdo
not cover travel and accommodation costs. Following completion and return of the registration form
including the authorized signature, full payment is required within 5 working days from receipt of invoice.
PLEASE NOTE: payment must be received prior to the conference date. Admission to the event cannot be
guaranteedifthepaymenthasnotbeenreceivedbyInformediaIndiaPvt.Ltd.
Provided the total fee has been paid, substitutions can be made at any time free of charge. Cancellations
must be received in writing bymail or fax 5 working days before the conference in order to qualify for a Credit
Note which will be valid for 6 months after the date of issue. Thereafter, a Credit note cannot be issued.
Nonpaymentornon-attendancedoesnotconstitutecancellation.If,foranyreason,InformediaIndiaPvt.Ltd.
decides to cancel or postpone this conference and / or workshop/s, Informedia India Pvt. Ltd. is not
responsibleforcoveringairfare,hotelorothertravelcostsincurredbythedelegate.Incaseofcancellationor
postponement, the fee qualifies for a credit note equal in value for any future event organized by Informedia
IndiaPvt.Ltd.
All Intellectual Property Rights in all materials produced or distributed by Informedia India Pvt. Ltd. in
connectionwiththiseventisexpresslyreservedandanyunauthorizedduplication,publicationordistribution
isprohibited.
Event programme content and the event venue can be subject to change without notice and does not impact
theTermsandConditionsspecifiedin1.and2.
With his or her signature, the delegate acknowledges that they have read and understood all terms of this
contractincluding,withoutlimitation,theprovisionsrelatingtocancellationandtopaymentterms.
Terms & Conditions
1.
2.
3.
4.
Please note that 12.36% service tax will be applicable on the above mentioned fees
Fees Package
Euro 1,399Euro 899
For International DelegatesFor Indian Delegates
Conference: 3rd - 4th December 2008 | Venue: Hotel J W Marriott, Mumbai
Juhu Tara Road,
Mumbai - 400 049, India
Tel: +91 22 66933000
Fax: +91 22 66933100
www.marriott.com
Best Practice in Service Outsourcing
Global Pharmaceuticals
Research & Manufacturing India 2008
Global Pharmaceuticals
Research & Manufacturing India 2008

Weitere ähnliche Inhalte

Was ist angesagt?

Project Management In Pharmaceutical Industry
Project Management In Pharmaceutical IndustryProject Management In Pharmaceutical Industry
Project Management In Pharmaceutical IndustryMegha Kotak, PMP
 
Complex Generics Overview - Outlooks and Challenges
Complex Generics Overview - Outlooks and ChallengesComplex Generics Overview - Outlooks and Challenges
Complex Generics Overview - Outlooks and ChallengesSanjay Chaturvedi
 
Pathways to Efficient Drug Development - Advances in Modeling and Simulation ...
Pathways to Efficient Drug Development - Advances in Modeling and Simulation ...Pathways to Efficient Drug Development - Advances in Modeling and Simulation ...
Pathways to Efficient Drug Development - Advances in Modeling and Simulation ...ReportsnReports
 
Introduction to pharmaceutical industry & clinical research
Introduction to pharmaceutical industry & clinical researchIntroduction to pharmaceutical industry & clinical research
Introduction to pharmaceutical industry & clinical researchBhaswat Chakraborty
 
Indian Pharmaceutical Export Market - Top Export Destinations for Indian Phar...
Indian Pharmaceutical Export Market - Top Export Destinations for Indian Phar...Indian Pharmaceutical Export Market - Top Export Destinations for Indian Phar...
Indian Pharmaceutical Export Market - Top Export Destinations for Indian Phar...Irish Pereira
 
Outsourcing in Clinical Research
Outsourcing in Clinical ResearchOutsourcing in Clinical Research
Outsourcing in Clinical ResearchMansi Gaikwad
 
Role of CRO’s in Medical Innovation and Drug Development
Role of CRO’s in Medical Innovation and Drug DevelopmentRole of CRO’s in Medical Innovation and Drug Development
Role of CRO’s in Medical Innovation and Drug DevelopmentJohn Douglas
 
Challenges in regulatory filing of generic products in Europe and Malyasia.
Challenges in regulatory filing of generic products in Europe and Malyasia.Challenges in regulatory filing of generic products in Europe and Malyasia.
Challenges in regulatory filing of generic products in Europe and Malyasia.rkreddy98666
 
Pharma Industry Overview
Pharma Industry OverviewPharma Industry Overview
Pharma Industry OverviewSudeep DSouza
 
Problems facing the pharmaceutical industry
Problems facing the pharmaceutical industryProblems facing the pharmaceutical industry
Problems facing the pharmaceutical industryKelly To
 
ReportsnReports – Point of Care Diagnostic Testing World Markets
ReportsnReports – Point of Care Diagnostic Testing World MarketsReportsnReports – Point of Care Diagnostic Testing World Markets
ReportsnReports – Point of Care Diagnostic Testing World MarketsReportsnReports
 
Managing change in organizations
Managing change in organizationsManaging change in organizations
Managing change in organizationsteimon
 
ARSTAT_Introduction
ARSTAT_IntroductionARSTAT_Introduction
ARSTAT_IntroductionArkady Rubin
 
Interview pharmatutor: Pharmacy Education and Pharmaceutical Industry
Interview pharmatutor: Pharmacy Education and Pharmaceutical IndustryInterview pharmatutor: Pharmacy Education and Pharmaceutical Industry
Interview pharmatutor: Pharmacy Education and Pharmaceutical IndustryBhaswat Chakraborty
 
Biopharmaceutical Manufacturing in India, China and South Korea - Regulatory ...
Biopharmaceutical Manufacturing in India, China and South Korea - Regulatory ...Biopharmaceutical Manufacturing in India, China and South Korea - Regulatory ...
Biopharmaceutical Manufacturing in India, China and South Korea - Regulatory ...ReportsnReports
 
Accelerating Generic Approvals by Dr Anthony Crasto
Accelerating Generic Approvals by Dr Anthony CrastoAccelerating Generic Approvals by Dr Anthony Crasto
Accelerating Generic Approvals by Dr Anthony CrastoAnthony Melvin Crasto Ph.D
 
Antares presentation -_january_2014
Antares presentation -_january_2014Antares presentation -_january_2014
Antares presentation -_january_2014rymankoly
 
Broad opportunities for pharmacists
Broad opportunities for pharmacistsBroad opportunities for pharmacists
Broad opportunities for pharmacistsBhaswat Chakraborty
 

Was ist angesagt? (20)

Pharmaceutical Industry: The Challenges and the Opportunities
Pharmaceutical Industry: The Challenges and the OpportunitiesPharmaceutical Industry: The Challenges and the Opportunities
Pharmaceutical Industry: The Challenges and the Opportunities
 
Project Management In Pharmaceutical Industry
Project Management In Pharmaceutical IndustryProject Management In Pharmaceutical Industry
Project Management In Pharmaceutical Industry
 
Complex Generics Overview - Outlooks and Challenges
Complex Generics Overview - Outlooks and ChallengesComplex Generics Overview - Outlooks and Challenges
Complex Generics Overview - Outlooks and Challenges
 
Pathways to Efficient Drug Development - Advances in Modeling and Simulation ...
Pathways to Efficient Drug Development - Advances in Modeling and Simulation ...Pathways to Efficient Drug Development - Advances in Modeling and Simulation ...
Pathways to Efficient Drug Development - Advances in Modeling and Simulation ...
 
Introduction to pharmaceutical industry & clinical research
Introduction to pharmaceutical industry & clinical researchIntroduction to pharmaceutical industry & clinical research
Introduction to pharmaceutical industry & clinical research
 
Indian Pharmaceutical Export Market - Top Export Destinations for Indian Phar...
Indian Pharmaceutical Export Market - Top Export Destinations for Indian Phar...Indian Pharmaceutical Export Market - Top Export Destinations for Indian Phar...
Indian Pharmaceutical Export Market - Top Export Destinations for Indian Phar...
 
Outsourcing in Clinical Research
Outsourcing in Clinical ResearchOutsourcing in Clinical Research
Outsourcing in Clinical Research
 
Role of CRO’s in Medical Innovation and Drug Development
Role of CRO’s in Medical Innovation and Drug DevelopmentRole of CRO’s in Medical Innovation and Drug Development
Role of CRO’s in Medical Innovation and Drug Development
 
Challenges in regulatory filing of generic products in Europe and Malyasia.
Challenges in regulatory filing of generic products in Europe and Malyasia.Challenges in regulatory filing of generic products in Europe and Malyasia.
Challenges in regulatory filing of generic products in Europe and Malyasia.
 
Pharma Industry Overview
Pharma Industry OverviewPharma Industry Overview
Pharma Industry Overview
 
Problems facing the pharmaceutical industry
Problems facing the pharmaceutical industryProblems facing the pharmaceutical industry
Problems facing the pharmaceutical industry
 
ReportsnReports – Point of Care Diagnostic Testing World Markets
ReportsnReports – Point of Care Diagnostic Testing World MarketsReportsnReports – Point of Care Diagnostic Testing World Markets
ReportsnReports – Point of Care Diagnostic Testing World Markets
 
Contract research
Contract researchContract research
Contract research
 
Managing change in organizations
Managing change in organizationsManaging change in organizations
Managing change in organizations
 
ARSTAT_Introduction
ARSTAT_IntroductionARSTAT_Introduction
ARSTAT_Introduction
 
Interview pharmatutor: Pharmacy Education and Pharmaceutical Industry
Interview pharmatutor: Pharmacy Education and Pharmaceutical IndustryInterview pharmatutor: Pharmacy Education and Pharmaceutical Industry
Interview pharmatutor: Pharmacy Education and Pharmaceutical Industry
 
Biopharmaceutical Manufacturing in India, China and South Korea - Regulatory ...
Biopharmaceutical Manufacturing in India, China and South Korea - Regulatory ...Biopharmaceutical Manufacturing in India, China and South Korea - Regulatory ...
Biopharmaceutical Manufacturing in India, China and South Korea - Regulatory ...
 
Accelerating Generic Approvals by Dr Anthony Crasto
Accelerating Generic Approvals by Dr Anthony CrastoAccelerating Generic Approvals by Dr Anthony Crasto
Accelerating Generic Approvals by Dr Anthony Crasto
 
Antares presentation -_january_2014
Antares presentation -_january_2014Antares presentation -_january_2014
Antares presentation -_january_2014
 
Broad opportunities for pharmacists
Broad opportunities for pharmacistsBroad opportunities for pharmacists
Broad opportunities for pharmacists
 

Ähnlich wie Global Pharmaceuticals R&D Programme

Summer internship project report ranabxy kishan kumar_2010096
Summer internship project report ranabxy kishan kumar_2010096Summer internship project report ranabxy kishan kumar_2010096
Summer internship project report ranabxy kishan kumar_2010096Kishankrduggal
 
Contract Research Organisations- CRO in Pharma Field
Contract Research Organisations- CRO in Pharma FieldContract Research Organisations- CRO in Pharma Field
Contract Research Organisations- CRO in Pharma FieldVINOTH R
 
Clinical Trials in India
Clinical Trials in IndiaClinical Trials in India
Clinical Trials in Indiavaatsalya
 
Vedic Lifesciences - Nutraceutical CRO
Vedic Lifesciences - Nutraceutical CROVedic Lifesciences - Nutraceutical CRO
Vedic Lifesciences - Nutraceutical CROJayesh Chaudhary
 
Pharma Focus Asia Issue 21
Pharma Focus Asia Issue 21Pharma Focus Asia Issue 21
Pharma Focus Asia Issue 21yahyasultan
 
Summer Internship Report
Summer Internship ReportSummer Internship Report
Summer Internship ReportPramod Patidar
 
A Study of generic drugs
A Study of generic drugsA Study of generic drugs
A Study of generic drugsSantosh Salgare
 
Pharmaceutical, Bulk Drugs and Medicine Manufacturing Industry (Production, F...
Pharmaceutical, Bulk Drugs and Medicine Manufacturing Industry (Production, F...Pharmaceutical, Bulk Drugs and Medicine Manufacturing Industry (Production, F...
Pharmaceutical, Bulk Drugs and Medicine Manufacturing Industry (Production, F...Ajjay Kumar Gupta
 
Guest editorial J Adv PharmTechRes
Guest editorial J Adv PharmTechResGuest editorial J Adv PharmTechRes
Guest editorial J Adv PharmTechResBhaswat Chakraborty
 
Drug Regulatory Affairs- 2
Drug Regulatory Affairs- 2Drug Regulatory Affairs- 2
Drug Regulatory Affairs- 2Tanuja Bisht
 
Pharmaceutical Offshoring Landscape A Syndicated Report
Pharmaceutical Offshoring Landscape A Syndicated ReportPharmaceutical Offshoring Landscape A Syndicated Report
Pharmaceutical Offshoring Landscape A Syndicated Reportshekhar619
 
“LET US KNOW ABOUT QUALITY BY DESIGN IN PHARMACEUTICAL INDUSTRY”
“LET US KNOW ABOUT QUALITY BY DESIGN IN PHARMACEUTICAL INDUSTRY”“LET US KNOW ABOUT QUALITY BY DESIGN IN PHARMACEUTICAL INDUSTRY”
“LET US KNOW ABOUT QUALITY BY DESIGN IN PHARMACEUTICAL INDUSTRY”Rajatmishra137
 
7th pharmacovigilance 2014
7th pharmacovigilance 20147th pharmacovigilance 2014
7th pharmacovigilance 2014Dinesh T
 
7th pharmacovigilance 2014
7th pharmacovigilance 20147th pharmacovigilance 2014
7th pharmacovigilance 2014Dinesh T
 
7th pharmacovigilance 2014
7th pharmacovigilance 20147th pharmacovigilance 2014
7th pharmacovigilance 2014Dinesh T
 
0601017 explore market opportunities for new product launch
0601017 explore market opportunities for new product launch0601017 explore market opportunities for new product launch
0601017 explore market opportunities for new product launchSupa Buoy
 

Ähnlich wie Global Pharmaceuticals R&D Programme (20)

Clinical Trials Summit 2015
Clinical Trials Summit 2015Clinical Trials Summit 2015
Clinical Trials Summit 2015
 
6th annual clinical trials summit 2015
6th annual clinical trials summit 20156th annual clinical trials summit 2015
6th annual clinical trials summit 2015
 
5th pharmacovigilance congregation 2013
5th pharmacovigilance congregation 20135th pharmacovigilance congregation 2013
5th pharmacovigilance congregation 2013
 
Summer internship project report ranabxy kishan kumar_2010096
Summer internship project report ranabxy kishan kumar_2010096Summer internship project report ranabxy kishan kumar_2010096
Summer internship project report ranabxy kishan kumar_2010096
 
Contract Research Organisations- CRO in Pharma Field
Contract Research Organisations- CRO in Pharma FieldContract Research Organisations- CRO in Pharma Field
Contract Research Organisations- CRO in Pharma Field
 
Clinical Trials in India
Clinical Trials in IndiaClinical Trials in India
Clinical Trials in India
 
Vedic Lifesciences - Nutraceutical CRO
Vedic Lifesciences - Nutraceutical CROVedic Lifesciences - Nutraceutical CRO
Vedic Lifesciences - Nutraceutical CRO
 
Pharma Focus Asia Issue 21
Pharma Focus Asia Issue 21Pharma Focus Asia Issue 21
Pharma Focus Asia Issue 21
 
Summer Internship Report
Summer Internship ReportSummer Internship Report
Summer Internship Report
 
A Study of generic drugs
A Study of generic drugsA Study of generic drugs
A Study of generic drugs
 
Pharmaceutical, Bulk Drugs and Medicine Manufacturing Industry (Production, F...
Pharmaceutical, Bulk Drugs and Medicine Manufacturing Industry (Production, F...Pharmaceutical, Bulk Drugs and Medicine Manufacturing Industry (Production, F...
Pharmaceutical, Bulk Drugs and Medicine Manufacturing Industry (Production, F...
 
Carrier in chemistry.pptx
Carrier in chemistry.pptxCarrier in chemistry.pptx
Carrier in chemistry.pptx
 
Guest editorial J Adv PharmTechRes
Guest editorial J Adv PharmTechResGuest editorial J Adv PharmTechRes
Guest editorial J Adv PharmTechRes
 
Drug Regulatory Affairs- 2
Drug Regulatory Affairs- 2Drug Regulatory Affairs- 2
Drug Regulatory Affairs- 2
 
Pharmaceutical Offshoring Landscape A Syndicated Report
Pharmaceutical Offshoring Landscape A Syndicated ReportPharmaceutical Offshoring Landscape A Syndicated Report
Pharmaceutical Offshoring Landscape A Syndicated Report
 
“LET US KNOW ABOUT QUALITY BY DESIGN IN PHARMACEUTICAL INDUSTRY”
“LET US KNOW ABOUT QUALITY BY DESIGN IN PHARMACEUTICAL INDUSTRY”“LET US KNOW ABOUT QUALITY BY DESIGN IN PHARMACEUTICAL INDUSTRY”
“LET US KNOW ABOUT QUALITY BY DESIGN IN PHARMACEUTICAL INDUSTRY”
 
7th pharmacovigilance 2014
7th pharmacovigilance 20147th pharmacovigilance 2014
7th pharmacovigilance 2014
 
7th pharmacovigilance 2014
7th pharmacovigilance 20147th pharmacovigilance 2014
7th pharmacovigilance 2014
 
7th pharmacovigilance 2014
7th pharmacovigilance 20147th pharmacovigilance 2014
7th pharmacovigilance 2014
 
0601017 explore market opportunities for new product launch
0601017 explore market opportunities for new product launch0601017 explore market opportunities for new product launch
0601017 explore market opportunities for new product launch
 

Kürzlich hochgeladen

Mihir Menda - Member of Supervisory Board at RMZ
Mihir Menda - Member of Supervisory Board at RMZMihir Menda - Member of Supervisory Board at RMZ
Mihir Menda - Member of Supervisory Board at RMZKanakChauhan5
 
Intellectual Property Licensing Examples
Intellectual Property Licensing ExamplesIntellectual Property Licensing Examples
Intellectual Property Licensing Examplesamberjiles31
 
PDT 88 - 4 million seed - Seed - Protecto.pdf
PDT 88 - 4 million seed - Seed - Protecto.pdfPDT 88 - 4 million seed - Seed - Protecto.pdf
PDT 88 - 4 million seed - Seed - Protecto.pdfHajeJanKamps
 
Borderless Access - Global B2B Panel book-unlock 2024
Borderless Access - Global B2B Panel book-unlock 2024Borderless Access - Global B2B Panel book-unlock 2024
Borderless Access - Global B2B Panel book-unlock 2024Borderless Access
 
The Vietnam Believer Newsletter_MARCH 25, 2024_EN_Vol. 003
The Vietnam Believer Newsletter_MARCH 25, 2024_EN_Vol. 003The Vietnam Believer Newsletter_MARCH 25, 2024_EN_Vol. 003
The Vietnam Believer Newsletter_MARCH 25, 2024_EN_Vol. 003believeminhh
 
Anyhr.io | Presentation HR&Recruiting agency
Anyhr.io | Presentation HR&Recruiting agencyAnyhr.io | Presentation HR&Recruiting agency
Anyhr.io | Presentation HR&Recruiting agencyHanna Klim
 
NewBase 25 March 2024 Energy News issue - 1710 by Khaled Al Awadi_compress...
NewBase  25 March  2024  Energy News issue - 1710 by Khaled Al Awadi_compress...NewBase  25 March  2024  Energy News issue - 1710 by Khaled Al Awadi_compress...
NewBase 25 March 2024 Energy News issue - 1710 by Khaled Al Awadi_compress...Khaled Al Awadi
 
To Create Your Own Wig Online To Create Your Own Wig Online
To Create Your Own Wig Online  To Create Your Own Wig OnlineTo Create Your Own Wig Online  To Create Your Own Wig Online
To Create Your Own Wig Online To Create Your Own Wig Onlinelng ths
 
PDT 89 - $1.4M - Seed - Plantee Innovations.pdf
PDT 89 - $1.4M - Seed - Plantee Innovations.pdfPDT 89 - $1.4M - Seed - Plantee Innovations.pdf
PDT 89 - $1.4M - Seed - Plantee Innovations.pdfHajeJanKamps
 
MC Heights construction company in Jhang
MC Heights construction company in JhangMC Heights construction company in Jhang
MC Heights construction company in Jhangmcgroupjeya
 
Michael Vidyakin: Introduction to PMO (UA)
Michael Vidyakin: Introduction to PMO (UA)Michael Vidyakin: Introduction to PMO (UA)
Michael Vidyakin: Introduction to PMO (UA)Lviv Startup Club
 
Plano de marketing- inglês em formato ppt
Plano de marketing- inglês  em formato pptPlano de marketing- inglês  em formato ppt
Plano de marketing- inglês em formato pptElizangelaSoaresdaCo
 
Talent Management research intelligence_13 paradigm shifts_20 March 2024.pdf
Talent Management research intelligence_13 paradigm shifts_20 March 2024.pdfTalent Management research intelligence_13 paradigm shifts_20 March 2024.pdf
Talent Management research intelligence_13 paradigm shifts_20 March 2024.pdfCharles Cotter, PhD
 
Fabric RFID Wristbands in Ireland for Events and Festivals
Fabric RFID Wristbands in Ireland for Events and FestivalsFabric RFID Wristbands in Ireland for Events and Festivals
Fabric RFID Wristbands in Ireland for Events and FestivalsWristbands Ireland
 
AMAZON SELLER VIRTUAL ASSISTANT PRODUCT RESEARCH .pdf
AMAZON SELLER VIRTUAL ASSISTANT PRODUCT RESEARCH .pdfAMAZON SELLER VIRTUAL ASSISTANT PRODUCT RESEARCH .pdf
AMAZON SELLER VIRTUAL ASSISTANT PRODUCT RESEARCH .pdfJohnCarloValencia4
 
Tata Kelola Bisnis perushaan yang bergerak
Tata Kelola Bisnis perushaan yang bergerakTata Kelola Bisnis perushaan yang bergerak
Tata Kelola Bisnis perushaan yang bergerakEditores1
 
Developing Coaching Skills: Mine, Yours, Ours
Developing Coaching Skills: Mine, Yours, OursDeveloping Coaching Skills: Mine, Yours, Ours
Developing Coaching Skills: Mine, Yours, OursKaiNexus
 
UNLEASHING THE POWER OF PROGRAMMATIC ADVERTISING
UNLEASHING THE POWER OF PROGRAMMATIC ADVERTISINGUNLEASHING THE POWER OF PROGRAMMATIC ADVERTISING
UNLEASHING THE POWER OF PROGRAMMATIC ADVERTISINGlokeshwarmaha
 
Ethical stalking by Mark Williams. UpliftLive 2024
Ethical stalking by Mark Williams. UpliftLive 2024Ethical stalking by Mark Williams. UpliftLive 2024
Ethical stalking by Mark Williams. UpliftLive 2024Winbusinessin
 
Boat Trailers Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opp...
Boat Trailers Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opp...Boat Trailers Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opp...
Boat Trailers Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opp...IMARC Group
 

Kürzlich hochgeladen (20)

Mihir Menda - Member of Supervisory Board at RMZ
Mihir Menda - Member of Supervisory Board at RMZMihir Menda - Member of Supervisory Board at RMZ
Mihir Menda - Member of Supervisory Board at RMZ
 
Intellectual Property Licensing Examples
Intellectual Property Licensing ExamplesIntellectual Property Licensing Examples
Intellectual Property Licensing Examples
 
PDT 88 - 4 million seed - Seed - Protecto.pdf
PDT 88 - 4 million seed - Seed - Protecto.pdfPDT 88 - 4 million seed - Seed - Protecto.pdf
PDT 88 - 4 million seed - Seed - Protecto.pdf
 
Borderless Access - Global B2B Panel book-unlock 2024
Borderless Access - Global B2B Panel book-unlock 2024Borderless Access - Global B2B Panel book-unlock 2024
Borderless Access - Global B2B Panel book-unlock 2024
 
The Vietnam Believer Newsletter_MARCH 25, 2024_EN_Vol. 003
The Vietnam Believer Newsletter_MARCH 25, 2024_EN_Vol. 003The Vietnam Believer Newsletter_MARCH 25, 2024_EN_Vol. 003
The Vietnam Believer Newsletter_MARCH 25, 2024_EN_Vol. 003
 
Anyhr.io | Presentation HR&Recruiting agency
Anyhr.io | Presentation HR&Recruiting agencyAnyhr.io | Presentation HR&Recruiting agency
Anyhr.io | Presentation HR&Recruiting agency
 
NewBase 25 March 2024 Energy News issue - 1710 by Khaled Al Awadi_compress...
NewBase  25 March  2024  Energy News issue - 1710 by Khaled Al Awadi_compress...NewBase  25 March  2024  Energy News issue - 1710 by Khaled Al Awadi_compress...
NewBase 25 March 2024 Energy News issue - 1710 by Khaled Al Awadi_compress...
 
To Create Your Own Wig Online To Create Your Own Wig Online
To Create Your Own Wig Online  To Create Your Own Wig OnlineTo Create Your Own Wig Online  To Create Your Own Wig Online
To Create Your Own Wig Online To Create Your Own Wig Online
 
PDT 89 - $1.4M - Seed - Plantee Innovations.pdf
PDT 89 - $1.4M - Seed - Plantee Innovations.pdfPDT 89 - $1.4M - Seed - Plantee Innovations.pdf
PDT 89 - $1.4M - Seed - Plantee Innovations.pdf
 
MC Heights construction company in Jhang
MC Heights construction company in JhangMC Heights construction company in Jhang
MC Heights construction company in Jhang
 
Michael Vidyakin: Introduction to PMO (UA)
Michael Vidyakin: Introduction to PMO (UA)Michael Vidyakin: Introduction to PMO (UA)
Michael Vidyakin: Introduction to PMO (UA)
 
Plano de marketing- inglês em formato ppt
Plano de marketing- inglês  em formato pptPlano de marketing- inglês  em formato ppt
Plano de marketing- inglês em formato ppt
 
Talent Management research intelligence_13 paradigm shifts_20 March 2024.pdf
Talent Management research intelligence_13 paradigm shifts_20 March 2024.pdfTalent Management research intelligence_13 paradigm shifts_20 March 2024.pdf
Talent Management research intelligence_13 paradigm shifts_20 March 2024.pdf
 
Fabric RFID Wristbands in Ireland for Events and Festivals
Fabric RFID Wristbands in Ireland for Events and FestivalsFabric RFID Wristbands in Ireland for Events and Festivals
Fabric RFID Wristbands in Ireland for Events and Festivals
 
AMAZON SELLER VIRTUAL ASSISTANT PRODUCT RESEARCH .pdf
AMAZON SELLER VIRTUAL ASSISTANT PRODUCT RESEARCH .pdfAMAZON SELLER VIRTUAL ASSISTANT PRODUCT RESEARCH .pdf
AMAZON SELLER VIRTUAL ASSISTANT PRODUCT RESEARCH .pdf
 
Tata Kelola Bisnis perushaan yang bergerak
Tata Kelola Bisnis perushaan yang bergerakTata Kelola Bisnis perushaan yang bergerak
Tata Kelola Bisnis perushaan yang bergerak
 
Developing Coaching Skills: Mine, Yours, Ours
Developing Coaching Skills: Mine, Yours, OursDeveloping Coaching Skills: Mine, Yours, Ours
Developing Coaching Skills: Mine, Yours, Ours
 
UNLEASHING THE POWER OF PROGRAMMATIC ADVERTISING
UNLEASHING THE POWER OF PROGRAMMATIC ADVERTISINGUNLEASHING THE POWER OF PROGRAMMATIC ADVERTISING
UNLEASHING THE POWER OF PROGRAMMATIC ADVERTISING
 
Ethical stalking by Mark Williams. UpliftLive 2024
Ethical stalking by Mark Williams. UpliftLive 2024Ethical stalking by Mark Williams. UpliftLive 2024
Ethical stalking by Mark Williams. UpliftLive 2024
 
Boat Trailers Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opp...
Boat Trailers Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opp...Boat Trailers Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opp...
Boat Trailers Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opp...
 

Global Pharmaceuticals R&D Programme

  • 1. Informedia proudly presents the inaugural conference on For more details, visit www.globalpharma-summit.com Best Practice in Service Outsourcing Conference: 3rd - 4th December 2008 | Venue: Hotel J W Marriott, Mumbai Global Pharmaceuticals Research & Manufacturing India 2008 Global Pharmaceuticals Research & Manufacturing India 2008 n nActis Biologics nAll India Institute of Medical Sciences nAmgen India nAstraZeneca Pharma nCadila Pharmaceuticals nDr Reddy's Laboratories nEisai India nEli Lilly &Co. nEvolva Biotech nFDA Maharashtra State nGlaxoSmithKline Pharmaceuticals nInstitute of Clinical Research India nNishith Desai Associates nNovartis nNycomed Pharma USA nPfizer nSandoz nSanofi–Aventis nTakeda Global Research and Development nUSV nWockhardt nWyeth nZydus Cadila Abbott India Top Level Speakers from Ü Ü Ü Ü Ü Find out how to outsource your clinical trials to India Harness the benefits of Indian CRAMS/CSOs within the current global pharma business model Evaluate the implications of moving global R&D offshore to India Examine the influence and input of biotech companies in the Indian pharma market Learn about the emerging and innovative business models for partnerships and collaboration Key Note Speakers Mr Ranga Iyer President OPPI and Managing Director Wyeth Mr Suhas Chaudhari Joint Commissioner (Greater Mumbai) FDA Maharashtra State Uma Nandan Misra Vice President - Operations & Site Manager AstraZeneca Pharma Mr Ranjit Shahani Vice Chairman, Managing Director and Country President Novartis Mr Harjit Singh, Senior Development Manager, Takeda Global Research and Development, UK Principal Media Partner Media Partners Online Media Partners International Media Partner
  • 2. 10.00 am Evaluating the implications of moving global R&D offshore vs outsourcing to India Globalisation of drug development processes What impact will Indian CROs have on shaping the global R&D landscape? Indian CROs view on the offshoring operations - how do they view their interaction and experiences when working with US and European pharmas? l m m Dr Chandrashekhar Potkar Managing Director, Clinical Research Pfizer 8.30 am Registration 9.00 am Chairman's Welcome and Opening Address 9.35 am Harnessing the benefits of Indian CRAMS/CSOs within the current global pharma business model Comparing CRO (Contract Research Organisation) and CM (Contract Manufacturing) activities within India, externally and looking at prospects for future development Retrospective analysis of how the CRAMS/CSOs business model has evolved - where we are now? Analysis of the long-term prospects for the CRAMS/CSOs industry and its ultimate effect on the Indian pharma business l m m Dr Ish Khanna Dr Reddy's Laboratories USA Mr Ranjit Shahani Vice Chairman, Managing Director and Country President Novartis 9.10 am Overview of the Indian pharma sector in an economic context What is the current development status of the industry? Is the cost advantage of investing in India now diminishing because of escalating operating costs? Dealing with the declining ROI of pharma businesses - proposed solutions to maintain sustainable growth of the industry Indian pharma in comparison to other emerging markets: China, South East Asia and Latin America Evaluating offshore process outsourcing from a regulatory and cost perspective Predicting future prospects: how the Indian economy is expected to develop - where will we be in 2020? l m m m m l Globalisation of the Indian pharma industrySession I: Wednesday 3rd December, 2008DAY 1: 2.40 pm Three years on from the Indian Patents Act 2005 Myths about patents Features of the Act Unfinished agenda Path forward l l l l Mr Ranga Iyer President, OPPI and Managing Director Wyeth 3.05 pm Pharmacovigilance, PMS and PSUR in India: Current status and the road map. Assessing the development of methodologies for monitoring drug safety Addressing the increasing concerns over drug safety and post-approval surveillance Ensuring proactive pharmacovigilance throughout the product lifecycle Improving patient safety by increasing the transparency of safety data Transferring the pharmacovigilance advancements of the West to emerging markets Exploring the relationship between pharmacovigilance and risk management l l l l l Mr YK Gupta Head, Department of Pharmacology, Zonal Pharmacovigilance Centre All India Institute of Medical Sciences 10.25 am Morning Refreshments & Networking Break 11.20 am The evolving regulation landscape in India Discussing the current Indian regulatory environment Recognising the requirements of Indian regulations towards approval of drugs developed Ensuring effective protection of intellectual property rights and development processes Standard operating procedures for conducting clinical trials in India - Schedule Y of the Drugs and Cosmetics Act in India and guidelines for biomedical research l l l l Dr Surinder Singh Drugs Controller General of India * Mr Suhas Chaudhari Joint Commissioner (Greater Mumbai) FDA, Maharashtra State 10.55 am Harmonisation of the global pharma regulatory environment Evaluating the impact of globalisation on the pharma regulatory landscape and how this will affect research and manufacturing processes Finding a common set of regulations which are acceptable to all countries l l Indian and worldwide regulatory policies and legislative framework Session II: 2.00 pm The viewpoint from two industry specialists on managing legal and regulatory considerations in clinical outsourcing The patent regime and present status of R&D in India Government initiatives to shorten the clinical trials application time Clinical research landscape in India Discussing the market prospects for further development Analysing the reason for the gap in the amount of research between India and the rest of the world Investigating pharmacovigilance practices in India for the clinical trials market and for future REITs l m l m m l Dr SK Gupta, Director General Institute of Clinical Research India Ms Gowree Gokhale, Partner Nishith Desai Associates www.globalpharma-summit.com For an Updated Conference Programme, Please log on to: * Awaiting final confirmation 12.30 pm Luncheon 11.45 am SPEED NETWORKING The quicker way to do business 3rd - 4th December, 2008 Global PharmaceuticalsGlobal Pharmaceuticals Research & Manufacturing India 2008
  • 3. 3.30 pm Dr Sham Nikam, Chief Scientific Officer Nycomed Pharma USA Evaluating the current status of drug R&D in India Drug discovery in India, along with CROs in Indian pharma industry Exploring the contract research market from preclinical to phase 3 Emerging opportunities for conducting exploratory proof-of concept studies Trends on outsourcing drug discovery and development (DD&D) Producing cost-effective NCEs (New Chemical Entities) targeting lifestyle, resistant infectious diseases with improved efficacy and minimal side effect Producing a pipeline of promising drug candidates - DD&D and NCEs l m m l m m 4.15 pm Dr PM Murali, Managing Director Evolva Biotech Building an indigenous value based ecosystem for cost effective drug discovery in India. Six key aspects leading to a sub half billion dollar NDA in the future Indian discovery landscape INVESTMENT: Arrival of startup VCs redefining the discovery landscape in India – those with longer acceptable incubation periods for their ROI and a higher risk taking ability EXPERTISE: Influx of returning Indians from elsewhere with prior experience in drug discovery and development FACILITIES: Availability of world class CRAMS/CSOs in biology, chemistry and pharmacology RESEARCH CONSULTANTS: Networking with scientific clusters of excellence, who are willing to collaborate with industry INTERFACE & SCALEUP OPERATIONS: English speaking population and FDA approved facilities – both available with largest numbers outside United States CLINICAL TRIALS: Huge patient population with diversity and CSIR's efforts in systematic mapping of heterogenicity, enables effective clinical trials, pharmacogenomics and pharmacovigilance l l l l l l Dr Veena Jaguste, Director, Global Development Operations, Amgen India 4.40 pm The impact of outsourcing on drug development performance and implications for more effective collaboration with CROs Clinical research and trials outsourcing - overcoming challenges and impediments Incorporating emerging regions into clinical development plans - a unique set of opportunities and challenges l l Mr Harjit Singh, Senior Development Manager Takeda Global Research and Development UK 5.05 pm Clinical research and trials outsourcing - challenges and hurdles in India Conducting phase 1 and 2 clinical trials in India Clinical quality assurance and its significance in global drug registration Clinical safety and risk evaluation in trials Conducting ethical clinical trials Managing clinical trial sites successfully Feasibility studies for investigational site selection Non clinical: technical and operational procedures and how to address them l l l l l l l 3.55 pm Afternoon Refreshments & Networking Break Mr Sanjeev Saxena Chairman and CEO Actis Biologics Evaluating the influence and input of biotech firms on the Indian pharma market Evaluating global biotechnology development and India's role in the process Ensuring global biotech opportunities within India and overseas Gaining advantage of innovative bio-technologies Forming partnerships with Indian biotech firms l l l l 9.10 am Thursday 4th December, 2008DAY 2:R&D in India: the landscape of opportunities and challenges Session III: 8.30 am Registration 9.00 am Chairman's Opening Remarks Emerging trends in biotechnologySession IV: Benefits of contract manufacturing for Indian producers Session V: 10.40 am Morning Refreshments & Networking Break 9.35 am Mr Subash Kapre * Executive Director Serum Institute of India Key issues affecting biopharmaceutical manufacturing Manufacturing biologics from the CMO (Contract Manufacturing Organisation) perspective Where is biopharma manufacturing going in the next 10 years? Regulatory initiatives impacting biopharmaceutical development and manufacturing Entry of biosimilar and bio-generic products Ensuring quality and safety in bio-processes Strategies for ensuring product comparability and safety after manufacturing process changes l l l l l m 10.00 am Global harmonisation and the perception of Indian CM to the rest of the pharma industry Evaluating international trends and global harmonisation opportunities CMO management throughout the relationship between CMO and outsourcer lifecycle Obtaining and understanding how process changes can affect the structure and biological activity of the final product (in technology transfer) Implementing successful approaches in manufacturing Evaluating the role of globalisation on the regulatory landscape and manufacturing process Contract manufacturing - in house vs outsourcing Emerging fields in the pharma outsourcing market - why should you outsource manufacturing and risk costly technology transfer delays? A critical assessment of the current manufacturing outsourcing strategies l l l l l l l l Mr Sanjit Lamba, President and CEO Eisai India Mr Lakshminarayana Neti, Director Operations Abbott India For enquiries write to jayesh.kanaskar@informedia-india.com5.40 pm Informedia’s Cocktail Reception 5.30 pm Chairman's Closing Remarks and End of Day One * Awaiting final confirmation 3rd - 4th December, 2008 Global PharmaceuticalsGlobal Pharmaceuticals Research & Manufacturing India 2008
  • 4. Mr Uma Nandan Misra Vice President, Operations and Site Manager AstraZeneca Pharma 11.50 am Case Study - Achieving operational excellence in a pharma manufacturing plant Cultural transformation Aligning manufacturing priorities with business Identifying & monitoring critical performance parameters Engaging all employees for continuous improvement Achieving excellence in focussed areas l l l l l 12.55 pm Luncheon 2.10 pm Implementing strategies to ensure that the contractors comply with quality agreements Compliance with GMP requirements Demonstrating how cGMP is essential for survival in the pharma business Gain a competitive edge with a GMP compliant designed facility Learn the importance of well written procedures, validation, documentation and SOPs for cGMP compliance l m m m Dr PM Naik Project Director Zydus Cadila Evolving partnering and business modelsSession VI: 2.35 pm Implementation of risk management strategies in outsourced manufacturing Risk and risk management in pharmaceutical and biopharmaceutical outsourcing Measuring risk as a preventative technique - ensuring operational excellence Identifying, understanding and rating risk throughout all processes Implementing effective methods to avoid risk Identifying and overcoming cost issues in CM outsourcing l l m m m Mr TS Anand Director, Contract Manufacturing and Outsourcing Dr Reddy's Laboratories 3.00 pm Innovative models of collaborating opportunities with CRAMS/CSOs Different models of collaboration that can be established between Indian firms and MNCs New business and partnership models evolving in India In and out licensing of drug discovery research Partnering opportunities - strategic involvements l l l l Ms Mukta Arora Head of Global Sourcing Eli Lilly & Co. 3.45 pm External sourcing in the pharma space Requirements for external sourcing Basic aspects of external sourcing Challenges faced by the Indian pharma business as compared to international businesses and other sectors How do you choose the right partner? Relationship building for the longer term - an essential part of the pharma business Legal and contractual issues l l l l l l Mr Debabrata Gupta Director and Chief Operating Officer USV 4.45 pm 4.35 pm End of Day Two and Close of the Conference Chairman's Closing Remarks 4.10 pm What are the strengths that the outsourcing organisation is looking for while selecting the CRAMS/CSOs? What the contract givers and contract acceptors should be aware of to continue long-term business relationships Who is the owner of the intellectual property developed during the cooperation and why? How to face audits from the outsourcing organisation to get approved as a CSO Why continuous communication is essential in such a relationship Why the customer should be kept informed of the failures and mistakes that take place At what stage does the product need to be optimised during CRO or CSO? How process changes from established practice could affect the customer and the relationship l l l l l l l Dr Sunil Kanvinde Deputy General Manager, Technical Services Sandoz 11.10 am Two key opinion leaders demonstrate how to establish successful technology transfer in CMO to ensure an effective manufacturing process Technology transfer for outsourcing and contract manufacture Implementing technology transfer to ensure an effective manufacturing process Critical factors and timelines for a successful technology transfer Success factors during process comparability and validation Developing and implementing clear quality agreements with CMOs Incorporating knowledge to ensure process comparability, validation and GMP requirements l l l l l l Mr KK Ambardar, General Manager, Contract Manufacturing, Cadila Pharmaceuticals Dr Ashoke Banerjee, Executive Director GlaxoSmithKline Pharmaceuticals 12.15 pm Panel Session: Two industry leaders viewpoint on quality management - developing and implementing sustainable quality agreements with CMOs What are the ‘rules of engagement’ between the sponsor and client for proper management of mutual quality and quality-regulatory needs in an outsourcing arrangement? One size does not fit all - How to design and put a workable and sustainable quality management system into practice? How does a quality agreement separate or link to other agreements like commercial and technical? What are the regulatory and legal requirements that should be addressed in a quality agreement? How should critical quality activities of change management, deviations, investigations, product release, GMP audits and regulatory inspections be integrated in to a good quality agreement? l l l l l Mr Satish Rajkondawar, Senior Director, External Manufacturing Site, Sanofi-Aventis Mr Viswajit Sahu, DGM Contract Manufacturing Services, Wockhardt 3.25 pm Afternoon Refreshments & Networking Break 3rd - 4th December, 2008 Global PharmaceuticalsGlobal Pharmaceuticals Research & Manufacturing India 2008
  • 5. About Informedia Informedia India Pvt Ltd is a leading conference organiser which specialises in professional high level business conferences targeted at senior management in a number of industry sectors. We are a subsidiary company of the Expomedia Group Plc., a leading International media group with offices in 13 countries worldwide. Dedicated to in-depth research, our conferences provide you with relevant information about what you want to know, when, and from whom. Straightforward and industry oriented, our conferences are a very time efficient way to gain a head start and secure your competitive advantage. Our focused events create a platform to network with both new and experienced peers from various industries and feature the most relevant case scenarios in order to equip you with valuable knowledge and current know-how. www.informedia-india.com Attracting the industry's most powerful and influential delegates àBusiness Development àClinical Research Outsourcing àManufacturing àDrug Discovery & Development àMedical Affairs àPharmaceutical Development àPharmacoviligance àPreclinical Development àProcurement àProduction Planning & Manufacturing àPurchasing àQuality Control & Assurance àRegulatory Affairs àRisk & Safety Assessment Heads of Divisions àCXOs àProject Directors Who will be there? The Global Pharmaceuticals conference has been developed with the following executives in mind: Which industry sectors should attend? àPharmaceutical Companies àBiotech Companies àCROs and CMOs àPharmaceutical Manufacturers àResearch Laboratories and Institutes àBusiness Consulting Firms àGovernment Institutions and Regulators àPrivate Equity Funds àVenture Capitalists Sponsorship... helps you to do business and deliver your message to the Global Pharmaceutical market. Contact our Sponsorship Director on sponsorship@expomediagroup.com or call +91 22-28500104 in India and +44 (0) 1923 491 067 in the UK to tailor your package Q.1 Could you benefit from presenting a case study or hosting a workshop in front of your target audience and demonstrating your expertise? If your answer is yes to any of these questions then the Global Pharmaceuticals Research and Manufacturing India 2008 is the most important place for you to be. 6 simple questions to determine value from sponsorship Q.2 Do you want to do business with senior decision makers from the leading Pharmaceutical and Biotech companies from India, Asia and the rest of the World? Q.3 Can you benefit from the impact of outsourcing on Clinical Research or Contract Manufacturing? Q.4 Can you provide a solution to the bad perception of manufacturing from a CMO's perspective? Q.6 Do you want to collaborate on drug development performance with CRO's? Q.5 Are you able to demonstrate the best way to run effective proof of concept trials? Sponsoring the Global Pharmaceuticals Research and Manufacturing India 2008 forum will enable you to: Raise your company’s profile Increase your chances of being chosen as the logical choice of supplier, when they hear and see you can exceed their needs. Don't pass business opportunities by, whilst your competitors walk away with them. Find your all year round marketing solution There are a limited number of opportunities for you to get your message across to the leading International Pharmaceutical and Biotechnology Companies, so act now to avoid disappointment. Put simply, you can't afford to miss out! The conference helps you to overcome common business development hurdles, like access and face to face networking with the right people with hours of scheduled networking time. Global Pharmaceuticals will put you face to face with people that matter in this industry. Join our existing partners at this prestigious event
  • 6. REGISTRATION FORM HOTEL INFORMATION Hotel J W Marriott www.globalpharma-summit.com I / We / would like to attend / nominate the following Please tick I enclose my Cheque/Draft payable to INFORMEDIA INDIA PVT. LTD. by post at 204-205, Town Centre, Andheri-Kurla Road, Sakinaka, Andheri (E), Mumbai - 400059 I am paying by bank transfer (copy attached) I cannot attend this event but I would like to purchase the Conference Documentation for Euro 150 + 12.36 % Service Tax Please do not include me on your mailing list REGISTER NOW in 3 Easy Steps Call: Sarfraz Patel Cell: +91 98 33487628 Tel: +91 22 40820183 Fax: +91 22 28509590 Register Online www.globalpharma-summit.com 1 2 3 Delegate 1 Delegate 2 Delegate 3 Designation Tel/Mobile/Fax Email ID Organisation Address Approving Authority Name Pin Code Name/ Designation Signature Feesareinclusiveofallprogrammedocuments,lunchonbothconferencedaysandrefreshments.Thefeesdo not cover travel and accommodation costs. Following completion and return of the registration form including the authorized signature, full payment is required within 5 working days from receipt of invoice. PLEASE NOTE: payment must be received prior to the conference date. Admission to the event cannot be guaranteedifthepaymenthasnotbeenreceivedbyInformediaIndiaPvt.Ltd. Provided the total fee has been paid, substitutions can be made at any time free of charge. Cancellations must be received in writing bymail or fax 5 working days before the conference in order to qualify for a Credit Note which will be valid for 6 months after the date of issue. Thereafter, a Credit note cannot be issued. Nonpaymentornon-attendancedoesnotconstitutecancellation.If,foranyreason,InformediaIndiaPvt.Ltd. decides to cancel or postpone this conference and / or workshop/s, Informedia India Pvt. Ltd. is not responsibleforcoveringairfare,hotelorothertravelcostsincurredbythedelegate.Incaseofcancellationor postponement, the fee qualifies for a credit note equal in value for any future event organized by Informedia IndiaPvt.Ltd. All Intellectual Property Rights in all materials produced or distributed by Informedia India Pvt. Ltd. in connectionwiththiseventisexpresslyreservedandanyunauthorizedduplication,publicationordistribution isprohibited. Event programme content and the event venue can be subject to change without notice and does not impact theTermsandConditionsspecifiedin1.and2. With his or her signature, the delegate acknowledges that they have read and understood all terms of this contractincluding,withoutlimitation,theprovisionsrelatingtocancellationandtopaymentterms. Terms & Conditions 1. 2. 3. 4. Please note that 12.36% service tax will be applicable on the above mentioned fees Fees Package Euro 1,399Euro 899 For International DelegatesFor Indian Delegates Conference: 3rd - 4th December 2008 | Venue: Hotel J W Marriott, Mumbai Juhu Tara Road, Mumbai - 400 049, India Tel: +91 22 66933000 Fax: +91 22 66933100 www.marriott.com Best Practice in Service Outsourcing Global Pharmaceuticals Research & Manufacturing India 2008 Global Pharmaceuticals Research & Manufacturing India 2008